SEC Company Response from CLOROX (CLX) — Mar 1, 2022
CLOROX CO /DE/ (CLX) (CIK 0000021076)
Date: March 1, 2022 · CIK: 0000021076 · Accession: 0001206774-22-000573
AI Filing Summary & Sentiment
File numbers found in text: 001-07151
Referenced dates: February 25, 2022
Letter
Form 10-K for the Fiscal Year Ended June 30, 2021 Form 10-Q for the Period Ended December 31, 2021 Form 8-K Filed February 3, 2022 File No. 001-07151
Re:
Dear Ms. Salik:
We hereby acknowledge receipt of the above referenced letter. Per your discussion with Laura Peck, Vice President – Chief Accounting Officer & Corporate Controller, on February 28, 2022, we hereby confirm that we will respond to the above referenced letter on or before March 18, 2022. If you have any questions or need any additional information, please contact me at (510) 271-6572 or jinho.joo@clorox.com.
Sincerely,
/s/ Jinho Joo
Show Raw Text
CORRESP 1 filename1.htm March 1, 2022 Ms. Nudrat Salik Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: SEC Comment Letter dated February 25, 2022 The Clorox Company Form 10-K for the Fiscal Year Ended June 30, 2021 Form 10-Q for the Period Ended December 31, 2021 Form 8-K Filed February 3, 2022 File No. 001-07151 Dear Ms. Salik: We hereby acknowledge receipt of the above referenced letter. Per your discussion with Laura Peck, Vice President – Chief Accounting Officer & Corporate Controller, on February 28, 2022, we hereby confirm that we will respond to the above referenced letter on or before March 18, 2022. If you have any questions or need any additional information, please contact me at (510) 271-6572 or jinho.joo@clorox.com. Sincerely, /s/ Jinho Joo Jinho Joo Senior Director cc: Kevin Jacobsen Executive Vice President – Chief Financial Officer Angela Hilt Senior Vice President – Chief Legal Officer Laura Peck Vice President – Chief Accounting Officer & Corporate Controller